MiNK Therapeutics (INKT) Misses Q3 EPS by 65c
Tweet
Share
E-mailGet Alerts INKT Hot Sheet
Join SI Premium – FREE
MiNK Therapeutics (NASDAQ: INKT) reported Q3 EPS of ($0.65).
For earnings history and earnings-related data on MiNK Therapeutics (INKT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apple investigating exposure to Tata Electronics data breach, full analysis underway - Reuters
- UWMC urges Two Harbors stockholders to reject CCM merger deal
- Popular stocks with increasing option volume: SPCX INTC AVGO AMC MU PLTR NYT
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
